![Company](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_CMN_Companies_to_Follow_2023_01_17_81d7a58868_1c503a0f51.png)
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
CasCure Therapeutics
Main focus: Next-generation cell therapies for autoimmune diseases
Company stage: Pre-clinical
Diseases (gene editing): Solid tumours
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: Ulsan and Seoul, Korea
Website: http://cascure.com/
![](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_cascure_2cd7a37d7a_36014fe845.png)
CasCure Therapeutics develops a novel method to selectively target and kill cancer cells using CRISPR-Cas9 technology.